Opportunities in RNA Therapeutics market Growth Analysis and Forecast by 2035 RNA therapies have emerged as a promising treatment modality, with the potential to target and alter genes, modulate protein functions and broaden the range of druggable targets, thereby paving way for new avenues in disease diagnosis and treatment. With rise in government initiatives for early commercialization of pipeline therapies and active involvement of RNA therapeutics investors, we anticipate a variety of novel RNA based therapeutics to be developed, presenting lucrative opportunities for both short- and long-term investors. The financial opportunity within the RNA therapeutics market has been analyzed across the following segments:  Type of Therapy  mRNA Vaccines and Therapeutics  RNAi Therapeutics  RNA Aptamers  Therapeutic Area  Infectious Diseases  Genetic Disorders  Haematological Disorders  Metabolic Disorders  Ocular Disorders  Oncological Disorders  Renal Disorders  Route of Administration  Intradermal  Intramuscular  Intravenous  Intravitreal  Ophthalmic  Subcutaneous  Key Geographies  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America The Investor Series: Opportunities in the RNA Therapeutics Market (mRNA Therapeutics and Vaccines, RNAi Therapeutics, and RNA Aptamers), detailed profiles of key public ventures engaged in the development of RNA therapeutics; each profile features a brief overview of the company, along with information on its management team, insights from its balance sheet (if available), as well as details related to its product portfolio, recent developments and key financials (including company investment highlights, company fundamental and company technical analysis).  Arcturus Therapeutics  Ascletis Pharma  Avidity Biosciences  BioNtech  CanSino Biologics  Gritstone bio  IVERIC bio  Moderna  Phio Pharmaceuticals  Vir Biotechnology Table of Contents Excel Deliverables 1. Innovators and Products Dataset 2. RNA therapeutics Funding and Investment Analysis 3. Company Valuation Analysis 4. Fundamental Financial Analysis 5. Technical Financial Analysis 6. Business Risk Analysis 7. Market Forecast and Opportunity Analysis 8. Return on Investment PowerPoint Deliverable 1. Context 2. Project Approach 3. Project Objective 4. Executive Summary Section I: Introduction to RNA Therapeutics and Innovators Landscape 5. The RNA Therapeutics Market 6. RNA Therapeutics: Innovators Landscape 7. RNA Therapeutics: Products Landscape and Company Health Indexing 8. Value Proposition Analysis 9. Company Competitiveness Analysis Section II: Analysis of RNA therapeutics Investment and Company Valuation 10. Funding and Investment Analysis 11. Company Valuation Analysis Section III: Financial Analysis and Assessment of Business Risks 12. Financial Analysis of Public Ventures 13. Company Profiles of Public Ventures 14. Business Risk Assessment Section IV: Market Forecast and Opportunity Analysis 15. Market Forecast and Opportunity Analysis Section V: Analysis of Returns on Investment and Key Acquisition Targets 16. Analysis of Return on Investment 17. Key Acquisition Targets 18. Conclusion 19. Appendices To view more details on this report, click on the link https://www.rootsanalysis.com/reports/opportunities-in-rna-therapeutics-market.html Learn from experts: do you know about these emerging industry trends? T-cell Immunotherapies: The Future of Modern Cancer Treatments Monkeypox: Disease Overview, Transmission and Diagnosis Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #RNAtherapeuticsmarketTrends #RNAtherapeuticsmarketGrowth #RNAtherapeuticsmarketopportunities #opportunitiesinRNAtherapeuticsmarket #RNAtherapeuticsfunding

Monkeypox Treatment market Growth Analysis by 2035 The recent rise in the incidence of the monkeypox disease, also known as Mpox, has compelled both industry players and regional government authorities to undertake active initiatives in order to control the spread of the disease Roots Analysis is pleased to announce the publication of its recent study, titled, “Monkeypox Market: Focus on Therapeutics, Vaccines and Diagnostic Kits, 2023-2035” The study features an extensive study of the current market landscape and future opportunity for the players focused on the development of monkeypox therapeutics, vaccines and diagnostic kits. Amongst other elements, the report features:  A general introduction to monkeypox virus, along with information on signs and symptoms of the disease, history of monkeypox outbreaks and details on transmission of disease from animals to humans and humans to humans.  A detailed assessment of the current market landscape of monkeypox therapeutics / vaccines that are approved / under development, based on several relevant parameters.  A detailed assessment of the current market landscape of monkeypox diagnostic kits, based on several relevant parameters.  A product competitiveness analysis of the Mpox diagnostic kits, based on supplier power and product competitiveness.  Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in monkeypox therapeutics / vaccines and diagnostic kits domain.  An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2018-2022 (till October).  An in-depth analysis on various grants, received since the year 2003, by players engaged in this field.  A detailed analysis of more than 200 peer-reviewed, scientific articles related to research on monkeypox therapeutics / vaccines and diagnostic kits, during the period of 2018-2022 (till September).  A qualitative analysis to understand the five competitive forces under an insightful Porter's Five Forces framework.  A detailed market forecast for monkeypox therapeutics / vaccines and diagnostic kits, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Type of Product  Therapeutics  Vaccines  Developer  Bavarian Nordic  Emergent BioSolutions  KM Biologics  SIGA Technologies  Type of Kit  Polymerase Chain Reaction (PCR) Detection Kits  Antigen Detection Kits  Antibody Detection Kits  Type of End User  Hospitals and Clinics  Diagnostic Laboratories  Other End Users  Key Geographical Regions  North America (US and Canada)  Europe (UK, France, Germany, Spain, Italy, Rest of EU)  Asia-Pacific (Japan and Australia)  Rest of the World  Transcripts of interviews held with the following senior level representatives of stakeholder companies:  Willy Tozoke Laou Man Cheong (Business Director, Hunan Runmei Gene Technology)  John W Sharkey (Vice President, Business Development, GeoVax)  Horace Lee (Sales Manager, Firegene)  Alan Yu (Sales Manager, Hangzhou Testsea Biotechnology) Key companies covered in the report  Bavarian Nordic  Emergent BioSolutions  ACON Laboratories  altona Diagnostics  DNA Software  Elabscience  Goldsite Diagnostics  Hangzhou Testsea Biotechnology  Jiangsu Bioperfectus Technologies  Lansion Biotechnology To view more details on this report, click on the link https://www.rootsanalysis.com/reports/monkeypox-treatment-market.html You may also be interested in the following titles: Decentralized Clinical Trials / Virtual Clinical Trials Market Global Antibiotics Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #mpoxmarket #monkeypoxmarket #Monkeypox #MarketResearch #MarketInsights

The global monkeypox therapeutics and vaccines market The recent rise in the incidence of the monkeypox disease, also known as Mpox, has compelled both industry players and regional government authorities to undertake active initiatives in order to control the spread of the disease For additional details, please visit https://www.rootsanalysis.com/reports/monkeypox-treatment-market.html